Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-08 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −4,630 66,460
2021-04-08 Pierce Christopher EVP and Chief of Business Oper Grant or award +200 $1.89 $378 3,950
2021-04-08 Pierce Christopher EVP and Chief of Business Oper Sale −200 $40.00 $8K 3,750
2021-04-08 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion · Employee Stock Option (right to buy) −200 7,618
2021-04-08 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion +100 $1.89 $189 544
2021-04-08 Morosini Deborah EVP, Chief of Clinical Affairs Sale −100 $40.00 $4K 444
2021-04-08 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion · Employee Stock Option (right to buy) −100 7,546
2021-04-08 Mauro David J Chief Medical Officer Exercise or conversion +9,617 $1.89 $18K 9,617
2021-04-08 Mauro David J Chief Medical Officer Sale −3,274 $37.04 $121K 6,343
2021-04-08 Mauro David J Chief Medical Officer Sale −1,501 $37.83 $57K 4,842
2021-04-08 Mauro David J Chief Medical Officer Sale −1,293 $39.00 $50K 3,549
2021-04-08 Mauro David J Chief Medical Officer Sale −3,549 $39.56 $140K 0
2021-04-08 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −9,617 277,610
2021-04-07 Scherle Peggy Chief Scientific Officer Grant or award +15,370 $1.43 $22K 188,290
2021-04-07 Scherle Peggy Chief Scientific Officer Sale −8,289 $39.02 $323K 180,001
2021-04-07 Scherle Peggy Chief Scientific Officer Sale −6,881 $39.63 $273K 173,120
2021-04-07 Scherle Peggy Chief Scientific Officer Sale −200 $40.30 $8K 172,920
2021-04-07 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −15,370 71,090
2021-04-07 Pierce Christopher EVP and Chief of Business Oper Grant or award +828 $1.89 $2K 4,578
2021-04-07 Pierce Christopher EVP and Chief of Business Oper Sale −828 $40.08 $33K 3,750

Page 14 of 19 · 369 trades